R. Bell

4.9k total citations · 1 hit paper
64 papers, 2.8k citations indexed

About

R. Bell is a scholar working on Oncology, Ecology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R. Bell has authored 64 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 13 papers in Ecology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R. Bell's work include Wildlife Ecology and Conservation (12 papers), Bone health and treatments (11 papers) and HER2/EGFR in Cancer Research (7 papers). R. Bell is often cited by papers focused on Wildlife Ecology and Conservation (12 papers), Bone health and treatments (11 papers) and HER2/EGFR in Cancer Research (7 papers). R. Bell collaborates with scholars based in United States, Australia and United Kingdom. R. Bell's co-authors include Hugo Jachmann, M. D. Gwynne, John J. Seaman, J.J. Body, F. Yunus, Erhard Quebe‐Fehling, Glenn Mills, Ehtesham Abdi, Alain Lortholary and Pierre Major and has published in prestigious journals such as Nature, JAMA and Journal of Clinical Oncology.

In The Last Decade

R. Bell

63 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials

2001 520 citations Pierre Major, Alain Lortholary et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Bell United States	22	1.7k	619	575	452	392	64	2.8k
Mark Quinn United Kingdom	30	181 0.1×	311 0.5×	99 0.2×	250 0.6×	173 0.4×	81	4.8k
Junko Morimoto Japan	30	384 0.2×	54 0.1×	229 0.4×	33 0.1×	118 0.3×	129	3.0k
Helen Wheeler Australia	12	1.1k 0.7×	531 0.9×	104 0.2×	282 0.6×	393 1.0×	26	1.8k
Michael J. Marshall United Kingdom	21	463 0.3×	132 0.2×	151 0.3×	174 0.4×	52 0.1×	62	1.7k
Lars‐Erik Holm Sweden	42	680 0.4×	764 1.2×	234 0.4×	8 0.0×	418 1.1×	135	5.5k
DE Williams United States	35	589 0.4×	135 0.2×	1.0k 1.8×	8 0.0×	145 0.4×	101	4.1k
Lorraine Robb Australia	39	1.2k 0.7×	90 0.1×	374 0.7×	9 0.0×	331 0.8×	52	6.4k
Mark S. Peterson United States	42	343 0.2×	86 0.1×	1.4k 2.4×	11 0.0×	874 2.2×	174	5.4k
Richard M. Hansen United States	37	1.9k 1.2×	76 0.1×	1.7k 3.0×	4 0.0×	810 2.1×	191	5.8k
Christian Fesl Austria	16	902 0.5×	179 0.3×	254 0.4×	115 0.3×	323 0.8×	50	1.5k

Countries citing papers authored by R. Bell

Since Specialization

Citations

This map shows the geographic impact of R. Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Bell more than expected).

Fields of papers citing papers by R. Bell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Bell. The network helps show where R. Bell may publish in the future.

Co-authorship network of co-authors of R. Bell

This figure shows the co-authorship network connecting the top 25 collaborators of R. Bell. A scholar is included among the top collaborators of R. Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Bell. R. Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wilson, Caroline, R. Bell, Samantha Hinsley, et al.. (2018). Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01/04) study. European Journal of Cancer. 94. 70–78. 36 indexed citations

Láng, István, R. Bell, R.I. Lopez, et al.. (2013). Trastuzumab Retreatment after Relapse on Adjuvant Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Final Results of the Retreatment after Herceptin Adjuvant Trial. Clinical Oncology. 26(2). 81–89. 24 indexed citations

Davis, Susan R., Robin J. Bell, Yuanyuan Wang, et al.. (2012). Aromatase inhibitors associated with knee subchondral bone expansion without cartilage loss. Climacteric. 16(6). 632–638. 2 indexed citations

Coleman, Robert E., Emma R. Woodward, Janet E. Brown, et al.. (2011). Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer. Breast Cancer Research and Treatment. 127(2). 429–438. 93 indexed citations

Coleman, Robert E., Matthew Winter, David Cameron, et al.. (2010). The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer. British Journal of Cancer. 102(7). 1099–1105. 168 indexed citations

Sewak, Sanjeev, Suzanne Kosmider, Vinod Ganju, et al.. (2009). Phase II study of paclitaxel and vinorelbine (Pacl‐Vin) in hormone‐refractory metastatic prostate cancer: double tubulin targeting. Internal Medicine Journal. 40(3). 201–208. 3 indexed citations

Collin, Peter D., et al.. (2008). Review of the Apoptosis Pathways in Pancreatic Cancer and the Anti‐apoptotic Effects of the Novel Sea Cucumber Compound, Frondoside A. Annals of the New York Academy of Sciences. 1138(1). 181–198. 70 indexed citations

Yang, Anthony D., Laleh G. Melstrom, David J. Bentrem, et al.. (2007). Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: An institutional experience. Surgery. 142(4). 529–537. 28 indexed citations

Venturini, M., Robert Paridaens, Michael Vaslamatzis, et al.. (2007). An Open-Label, Multicenter Study of Outpatient Capecitabine Monotherapy in 631 Patients with Pretreated Advanced Breast Cancer. Oncology. 72(1-2). 51–57. 16 indexed citations

10.

Oyama, Yu, Marina Talamonti, Mary F. Mulcahy, et al.. (2007). A phase I/II study of an antitumor vaccination using α (1,3) galactosyltransferase expressing allogeneic tumor cells in pancreatic cancer. Journal of Clinical Oncology. 25(18_suppl). 13512–13512. 1 indexed citations

11.

Body, Jean‐Jacques, Ingo Diel, A. F Lazarev, et al.. (2004). Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies. British Journal of Cancer. 90(6). 1133–1137. 229 indexed citations

12.

Bell, R.. (2001). Ongoing trials with trastuzumab in metastatic breast cancer. Annals of Oncology. 12. S69–S73. 10 indexed citations

13.

Major, Pierre, Alain Lortholary, Jeremy K. Hon, et al.. (2001). Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials. Journal of Clinical Oncology. 19(2). 558–567. 520 indexed citations breakdown →

14.

Berry, Scott, et al.. (1994). Thermal injury of the posterior duodenum during laparoscopic cholecystectomy. Surgical Endoscopy. 8(3). 197–200. 33 indexed citations

15.

Pettengill, Olive S., R A Faris, R. Bell, Elna T. Kuhlmann, & Daniel S. Longnecker. (1993). Derivation of ductlike cell lines from a transplantable acinar cell carcinoma of the rat pancreas.. PubMed. 143(1). 292–303. 47 indexed citations

16.

Rämö, O. J., et al.. (1990). Neuropeptide Y and peptide YY stimulate the growth of exocrine pancreatic carcinoma cells. Neuropeptides. 15(2). 101–106. 10 indexed citations

17.

Fisher, William E., et al.. (1988). Diabetes enhances growth of pancreatic carcinoma cells.. PubMed. 104(2). 431–6. 18 indexed citations

18.

Bell, R. & Mukunda B. Ray. (1987). Cytokeratin antigen in BOP-induced pancreatic tumors—implications for histogenesis. Carcinogenesis. 8(10). 1563–1566. 4 indexed citations

19.

Bell, R., et al.. (1984). Conservation and wildlife management in Africa : the proceedings of a workshop organized by the U.S. Peace Corps at Kasungu National Park, Malawi, October 1984. 7 indexed citations

20.

Jachmann, Hugo & R. Bell. (1984). Why do elephants destroy woodland?. Pachyderm. 3. 9–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact